AR106464A1 - RESPIRATORY SYNCTIAL VIRUS VACCINE - Google Patents

RESPIRATORY SYNCTIAL VIRUS VACCINE

Info

Publication number
AR106464A1
AR106464A1 ARP160103247A ARP160103247A AR106464A1 AR 106464 A1 AR106464 A1 AR 106464A1 AR P160103247 A ARP160103247 A AR P160103247A AR P160103247 A ARP160103247 A AR P160103247A AR 106464 A1 AR106464 A1 AR 106464A1
Authority
AR
Argentina
Prior art keywords
virus vaccine
respiratory synctial
synctial virus
vaccines
respiratory
Prior art date
Application number
ARP160103247A
Other languages
Spanish (es)
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of AR106464A1 publication Critical patent/AR106464A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vacunas de ácido ribonucleico (ARN) de virus sincitial respiratorio (RSV), así como a métodos para utilizar las vacunas y a composiciones que comprenden las vacunas. Reivindicación 123: Un ácido nucleico que codifica una vacuna de RSV de cualquiera de las reivindicaciones 116 - 122.Ribonucleic acid (RNA) vaccines of respiratory syncytial virus (RSV), as well as methods for using vaccines and compositions comprising vaccines. Claim 123: A nucleic acid encoding an RSV vaccine of any one of claims 116-122.

ARP160103247A 2015-10-22 2016-10-24 RESPIRATORY SYNCTIAL VIRUS VACCINE AR106464A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562245031P 2015-10-22 2015-10-22

Publications (1)

Publication Number Publication Date
AR106464A1 true AR106464A1 (en) 2018-01-17

Family

ID=61159871

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160103247A AR106464A1 (en) 2015-10-22 2016-10-24 RESPIRATORY SYNCTIAL VIRUS VACCINE
ARP160103246A AR106463A1 (en) 2015-10-22 2016-10-24 NUCLEIC ACID VACCINES FOR VARICELA-ZOSTER VIRUS (VZV)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP160103246A AR106463A1 (en) 2015-10-22 2016-10-24 NUCLEIC ACID VACCINES FOR VARICELA-ZOSTER VIRUS (VZV)

Country Status (1)

Country Link
AR (2) AR106464A1 (en)

Also Published As

Publication number Publication date
AR106463A1 (en) 2018-01-17

Similar Documents

Publication Publication Date Title
CL2018001053A1 (en) Vaccine against respiratory syncytial virus
MX2022006603A (en) Broad spectrum influenza virus vaccine.
PE20181531A1 (en) SIMPLE HERPES VIRUS VACCINE
MD3718565T2 (en) Respiratory virus vaccines
CY1125084T1 (en) NUCLEIC ACID VACCINES
EP3551193A4 (en) Respiratory virus nucleic acid vaccines
WO2018089851A3 (en) Influenza vaccine
PE20181529A1 (en) NUCLEIC ACID VACCINES FOR VARICELA-ZOSTER VIRUS (VZV)
WO2017070616A3 (en) Sexually transmitted disease vaccines
MA47787A (en) RESPIRATORY SYNCYTIAL VIRUS VACCINE
EA201790630A1 (en) METHODS OF OBTAINING RIBOSIDS
UY35873A (en) ? COMPOSITIONS AND METHODS FOR THE CONTROL OF VIRUSES IN THE VARROA MUSIC AND THE BEES ?.
BR112017003462A2 (en) attenuated bovine coronavirus, vaccine, and method of vaccination of a bovine.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
SI3400225T1 (en) Pentanoic acids substituted by pyrrolo-(2-3,b)pyrimidine-pyridines for the treatment of influenza viral infections
EP3455379A4 (en) Ribonucleic acid (rna) interactions
EP3939604A3 (en) Influenza hemagglutinin protein vaccines
EP3216875A3 (en) Methods for detecting pathogens piscine reovirus (prv), infectious pancreatic necrosis virus (ipnv), salmonid alphaviurs (sav), and infectious salmon anemia virus (isav) in coldwater fish
EP3545083A4 (en) Vaccines against infectious diseases caused by positive stranded rna viruses
UY34840A (en) SCHMALLENBERG VIRUS VACCINE (SBV), PRODUCTION METHODS AND ITS USES
EP3302544A4 (en) Nanoparticle based vaccine strategy against swine influenza virus
AR106464A1 (en) RESPIRATORY SYNCTIAL VIRUS VACCINE
CL2021001708A1 (en) Methods for forming polyplexes
MA39900A (en) Nucleic acid vaccines
EP3713600A4 (en) Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv)

Legal Events

Date Code Title Description
FB Suspension of granting procedure